One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy;Ein-jahresverlauf nach echokardiographisch geführter perkutaner septumablation bei hypertropher obstruktiver kardiomyopathie

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 15, 2001, Pages 424-430

  Seggewiss H ^a   Faber, L ^b   Ziemssen, P ^a   Gleichmann, U ^b  

^a Leopoldina Krankenhaus   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CLINICAL FEATURE; COMPLETE HEART BLOCK; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; SURGICAL TECHNIQUE; VALSALVA MANEUVER;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; TIME FACTORS;

EID: 0035848992     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12731     Document Type: Article

References (24)

1. Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment
2. Guiding of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography
3. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute and 3-months follow-up results with respect to myocardial contrast echocardiography
4. Abnormal blood pressure in hypertrophic cardiomyopathy
5. Acute and long-term results after transcoronary ablation of septal hypertrophy. Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
6. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie
7. Surgical management of hypertrophic obstructive cardiomyopathy: Early and late results
8. Pacing for obstructive hypertrophic cardiomyopathy
9. Die Alkoholkonzentration im Sinus coronarius nach transarterieller Ablation der Septumhypertrophie bei hypertropher obstruktiver Kardiomyopathie
10. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
11. Assessment of permanent dual - Chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double- blind, crossover study (M-PATHY)
12. New interventions for obstructive hypertrophic cardiomyopathy: Promise and prudence
13. Genes and disease expression in hypertrophic cardiomyopathy
14. Role of myocardial contrast echocardiography during nonsurgical reduction therapy for hypertrophic obstructive cardiomyopathy
15. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double blind, crossover trial
16. Muscular subaortic stenosis: The quantitative relationship between SAM and the pressure gradient
17. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
18. The committee on M-mode standardization of the American Society of Echocardiography
19. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus
20. Hypertrophe obstruktire Kardiomyopathie: Chirurgische Behandlung
21. Percutaneous transluminal septal myocardardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
22. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy
23. The management of hypertrophic cardiomyopathy
24. Hypertrophic cardiomyopathy: Clinical spectrum and treatment